Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A workflow for assessing antibody-drug conjugate target expression on circulating tumour cells from triple-negative breast cancer and epithelial ovarian cancer patients.

The journal of liquid biopsy·2026
Same author

IT Barriers and Enablers for Implementing Electronic Patient Reported Outcome Measures: A Multi-Site Qualitative Study in Nine European Oncology Clinics.

Studies in health technology and informatics·2026
Same author

Impact of non-genetic heterogeneity of BRAF-mutant colon cancer organoids on growth kinetics, drug sensitivity and Wnt dynamics.

International journal of cancer·2026
Same author

Adaptation of digital integration of PROMs and PREMs in oncology during implementation: a scoping review.

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer·2026
Same author

Multiplexed biomarkers dynamically detect heterogeneous residual neuroblastoma cell clone activity in the bone marrow niche.

Cancer letters·2026
Same author

Federal inspection timing, not compliance, associated with nursing home post-disaster outcomes.

Health affairs scholar·2026

Related Experiment Video

Updated: May 25, 2026

RNAscope for In situ Detection of Transcriptionally Active Human Papillomavirus in Head and Neck Squamous Cell Carcinoma
10:26

RNAscope for In situ Detection of Transcriptionally Active Human Papillomavirus in Head and Neck Squamous Cell Carcinoma

Published on: March 11, 2014

Towards a "Sample-In, Answer-Out" Point-of-Care Platform for Nucleic Acid Extraction and Amplification: Using an HPV

Anja Gulliksen1, Helen Keegan, Cara Martin

  • 1NorChip AS, Industriveien 8, 3490 Klokkarstua, Norway.

Journal of Oncology
|January 12, 2012
PubMed
Summary

This study developed an automated, hands-free diagnostic platform for detecting human papillomavirus (HPV) mRNA in clinical samples. The system successfully performed sample preparation, amplification, and detection, demonstrating a "sample-in, answer-out" capability.

More Related Videos

High-throughput Detection of Respiratory Pathogens in Animal Specimens by Nanoscale PCR
11:00

High-throughput Detection of Respiratory Pathogens in Animal Specimens by Nanoscale PCR

Published on: November 28, 2016

Employing Digital Droplet PCR to Detect BRAF V600E Mutations in Formalin-fixed Paraffin-embedded Reference Standard Cell Lines
10:16

Employing Digital Droplet PCR to Detect BRAF V600E Mutations in Formalin-fixed Paraffin-embedded Reference Standard Cell Lines

Published on: October 8, 2015

Related Experiment Videos

Last Updated: May 25, 2026

RNAscope for In situ Detection of Transcriptionally Active Human Papillomavirus in Head and Neck Squamous Cell Carcinoma
10:26

RNAscope for In situ Detection of Transcriptionally Active Human Papillomavirus in Head and Neck Squamous Cell Carcinoma

Published on: March 11, 2014

High-throughput Detection of Respiratory Pathogens in Animal Specimens by Nanoscale PCR
11:00

High-throughput Detection of Respiratory Pathogens in Animal Specimens by Nanoscale PCR

Published on: November 28, 2016

Employing Digital Droplet PCR to Detect BRAF V600E Mutations in Formalin-fixed Paraffin-embedded Reference Standard Cell Lines
10:16

Employing Digital Droplet PCR to Detect BRAF V600E Mutations in Formalin-fixed Paraffin-embedded Reference Standard Cell Lines

Published on: October 8, 2015

Area of Science:

  • Biotechnology
  • Molecular Diagnostics
  • Medical Devices

Background:

  • Cervical cancer screening relies on detecting high-risk human papillomavirus (HPV) types.
  • Current diagnostic methods often require complex laboratory procedures and skilled personnel.
  • There is a need for automated, user-friendly platforms for efficient HPV detection.

Purpose of the Study:

  • To develop and demonstrate a proof-of-principle, hands-free, and self-contained diagnostic platform for HPV E6/E7 mRNA detection.
  • To integrate automated sample preconcentration, nucleic acid extraction, amplification, and real-time detection.
  • To validate the platform's performance using clinical cervical cytology specimens.

Main Methods:

  • Development of two modular prototypes: one for sample preparation and one for amplification and detection.
  • Chip-based automation of sample preconcentration and nucleic acid extraction.
  • Real-time fluorescent detection using NASBA (Nucleic Acid Sequence-Based Amplification) technology.

Main Results:

  • The sample preparation module achieved HPV detection rates of 50%-85.7% across dilutions in 28 cervical cytology specimens.
  • Complete validation on the NASBA chip module showed 100% amplification for HPV 16 or 33 in 4 out of 6 clinical samples at a 1:10 dilution.
  • Successful demonstration of the integrated workflow from clinical sample input to final detection.

Conclusions:

  • The developed modular platform demonstrates the feasibility of a "sample-in, answer-out" diagnostic system for HPV mRNA detection.
  • The hands-free and automated nature of the platform minimizes user intervention, enhancing potential for widespread clinical use.
  • Further integration and optimization of the modules can lead to a fully automated, point-of-care HPV diagnostic solution.